Cargando…

Big data in IBD: big progress for clinical practice

IBD is a complex multifactorial inflammatory disease of the gut driven by extrinsic and intrinsic factors, including host genetics, the immune system, environmental factors and the gut microbiome. Technological advancements such as next-generation sequencing, high-throughput omics data generation an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seyed Tabib, Nasim Sadat, Madgwick, Matthew, Sudhakar, Padhmanand, Verstockt, Bram, Korcsmaros, Tamas, Vermeire, Séverine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Recent Advances in Clinical Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398484/ https://www.ncbi.nlm.nih.gov/pubmed/32111636 http://dx.doi.org/10.1136/gutjnl-2019-320065

Ejemplares similares

Computational Biology and Machine Learning Approaches to Understand Mechanistic Microbiome-Host Interactions
por: Sudhakar, Padhmanand, et al.
Publicado: (2021)

Distinct transcriptional signatures in purified circulating immune cells drive heterogeneity in disease location in IBD
por: Verstockt, Bram, et al.
Publicado: (2023)

What We Learned From Big Data for Autophagy Research
por: Jacomin, Anne-Claire, et al.
Publicado: (2018)

Understanding the Molecular Drivers of Disease Heterogeneity in Crohn’s Disease Using Multi-omic Data Integration and Network Analysis
por: Sudhakar, Padhmanand, et al.
Publicado: (2020)

Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All
por: Sudhakar, Padhmanand, et al.
Publicado: (2022)

Integrated analysis of microbe-host interactions in Crohn’s disease reveals potential mechanisms of microbial proteins on host gene expression
por: Sudhakar, Padhmanand, et al.
Publicado: (2022)

GlycA, a Nuclear Magnetic Resonance Spectroscopy Measure for Protein Glycosylation, is a Viable Biomarker for Disease Activity in IBD
por: Dierckx, Tim, et al.
Publicado: (2019)

COVID-19 and immunomodulation in IBD
por: Neurath, Markus F
Publicado: (2020)

A systems genomics approach to uncover patient-specific pathogenic pathways and proteins in ulcerative colitis
por: Brooks-Warburton, Johanne, et al.
Publicado: (2022)

MicroRNAs: new players in IBD
por: Kalla, R, et al.
Publicado: (2015)

Sherlock: an open-source data platform to store, analyze and integrate Big Data for computational biologists
por: Bohar, Balazs, et al.
Publicado: (2023)

Microbiota, not host origin drives ex vivo intestinal epithelial responses
por: Arnauts, Kaline, et al.
Publicado: (2022)

Recent advances in clinical practice: colorectal cancer chemoprevention in the average-risk population
por: Chapelle, Nicolas, et al.
Publicado: (2020)

Machine learning in GI endoscopy: practical guidance in how to interpret a novel field
por: van der Sommen, Fons, et al.
Publicado: (2020)

Recent advances in clinical practice: advances in cross-sectional imaging in inflammatory bowel disease
por: Rimola, Jordi, et al.
Publicado: (2022)

Recent advances in clinical practice: management of inflammatory bowel disease during the COVID-19 pandemic
por: Lin, Simeng, et al.
Publicado: (2022)

Monocyte TREM-1 Levels Associate With Anti-TNF Responsiveness in IBD Through Autophagy and Fcγ-Receptor Signaling Pathways
por: Prins, Marileen M., et al.
Publicado: (2021)

Inflammatory Bowel Disease (IBD)—A Textbook Case for Multi-Centric Banking of Human Biological Materials
por: Cleynen, Isabelle, et al.
Publicado: (2019)

Intestinal Receptor of SARS-CoV-2 in Inflamed IBD Tissue Seems Downregulated by HNF4A in Ileum and Upregulated by Interferon Regulating Factors in Colon
por: Verstockt, Bram, et al.
Publicado: (2020)

Applications of dual energy CT in clinical practice: A pictorial essay
por: Sanghavi, Parang S, et al.
Publicado: (2019)

Biomarker discovery for personalized therapy selection in inflammatory bowel diseases: Challenges and promises
por: Alsoud, Dahham, et al.
Publicado: (2022)

Intestinal microbiota in functional bowel disorders: a Rome foundation report
por: Simrén, Magnus, et al.
Publicado: (2013)

Symptomatic reflux disease: the present, the past and the future
por: Boeckxstaens, Guy, et al.
Publicado: (2014)

Expert opinions and scientific evidence for colonoscopy key performance indicators
por: Rees, Colin J, et al.
Publicado: (2016)

Critical research gaps and recommendations to inform research prioritisation for more effective prevention and improved outcomes in colorectal cancer
por: Lawler, Mark, et al.
Publicado: (2018)

Modern diagnosis of GERD: the Lyon Consensus
por: Gyawali, C Prakash, et al.
Publicado: (2018)

Assessment of Crohn’s disease-associated small bowel strictures and fibrosis on cross-sectional imaging: a systematic review
por: Bettenworth, Dominik, et al.
Publicado: (2019)

Guanylate cyclase-C as a therapeutic target in gastrointestinal disorders
por: Waldman, Scott A, et al.
Publicado: (2018)

Acute-on-chronic liver failure: an update
por: Hernaez, Ruben, et al.
Publicado: (2017)

Drug-induced liver injury: recent advances in diagnosis and risk assessment
por: Kullak-Ublick, Gerd A, et al.
Publicado: (2017)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges
por: Dufour, Jean-François, et al.
Publicado: (2020)

Update on lactose malabsorption and intolerance: pathogenesis, diagnosis and clinical management
por: Misselwitz, Benjamin, et al.
Publicado: (2019)

DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives
por: Perkhofer, Lukas, et al.
Publicado: (2021)

Endoscopy and central reading in inflammatory bowel disease clinical trials: achievements, challenges and future developments
por: Gottlieb, Klaus, et al.
Publicado: (2021)

Immunotherapy for advanced hepatocellular carcinoma: a focus on special subgroups
por: Pinter, Matthias, et al.
Publicado: (2021)

Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease
por: Urban, Stephan, et al.
Publicado: (2021)

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?
por: van Baar, Annieke C G, et al.
Publicado: (2021)

Novel therapeutic targets for cholestatic and fatty liver disease
por: Trauner, Michael, et al.
Publicado: (2022)

Understanding the role of the gut in undernutrition: what can technology tell us?
por: Thompson, Alex J, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_64rjd2q0gb5tp9sdp6s3u24pta